Business Context and Reporting Period
Company: Espey Mfg. & Electronics Corp.
Filing Type: Form 10-K (Annual Report)
Period Ended: June 30, 1997
Business Overview: The Company operates as a single-segment manufacturer of specialized electronic power conditioning apparatus, transformers, iron-core components, and electronic systems. Products are primarily used in military applications (radar, missile guidance, nuclear submarine control) and industrial sectors (locomotives, computers). A significant portion of sales is derived from U.S. Government contracts, primarily on a subcontract basis.
Key Financial Metrics
| Metric | Fiscal 1997 | Fiscal 1996 |
|---|---|---|
| Net Sales | $15,166,075 | $16,800,200 |
| Gross Profit | $2,150,639 | $1,827,182 |
| Gross Margin | 14.2% | 10.9% |
| Operating Income | $342,177 | $209,226 |
| Net Earnings | $563,128 | $522,737 |
| Earnings Per Share (EPS) | $0.51 | $0.41 |
| Working Capital | $21,220,719 | $20,875,897 |
| Total Assets | $25,199,951 | $24,950,043 |
| Long-Term Debt | $0 | $0 |
| Dividends Per Share | $0.70 | $0.70 |
Liquidity: The Company maintains a strong liquidity position with no long-term debt. Cash and short-term investments totaled $12,123,583 as of June 30, 1997. The Company funded all operations through cash flows from operating activities and did not borrow funds during the fiscal year.
Material Changes vs. Prior Period
- Revenue Decline: Net sales decreased approximately 10% to $15.17 million from $16.80 million in 1996. This decline was primarily attributed to the consolidation and relocation of facilities by a major customer, causing delays in ongoing and proposed programs.
- Margin Expansion: Despite lower sales, gross profit increased by 17.7%. The gross margin improved from 10.9% to 14.2% because contracts shipped in 1997 carried higher profit margins than those in the prior year. Cost of sales as a percentage of sales dropped from 89% to 86%.
- Profitability Increase: Net earnings rose 7.7% to $563,128, and EPS increased to $0.51 from $0.41. Operating income grew 63.5% to $342,177.
- Inventory Reduction: Total inventories decreased significantly from $11.03 million to $8.20 million, reflecting the reduction in backlog and a $385,000 pre-tax inventory write-off taken in the fourth quarter.
- Backlog Contraction: Firm sales backlog dropped from $16.30 million in 1996 to $9.04 million in 1997 due to the aforementioned customer consolidation.
Guidance, Outlook, and Risks
Outlook: Management anticipates that the backlog of $9.04 million will result in at least $8.00 million in shipments during fiscal 1998. The Company holds outstanding quotations exceeding $30.0 million for repeat and new programs. However, the realization of these orders is contingent upon the resolution of the major customer's consolidation and competitive market factors.
Management Commentary: The Company is addressing competitive price erosion by expanding efforts to develop proprietary technologies. Recent patent notices were received for a dental implant, a "Quiet" transformer for naval applications, and a dual dipole antenna. Management expects these innovations to enhance future revenues and profitability.
Risks and Contingencies:
- Customer Concentration: Two domestic customers accounted for 19.9% and 61.4% of total sales in 1997. The Company is heavily dependent on government appropriations and program allocations.
- Customer Consolidation: Ongoing delays from a major customer's facility consolidation pose a risk to the receipt of new business and the conversion of quotations to firm contracts.
- Inventory Write-off: A $385,000 inventory write-off in Q4 1997 caused a net loss for that quarter, reflecting orders that did not materialize as anticipated.
Investor Verification Checklist
- Customer Consolidation Impact: Verify the status of the major customer's consolidation and its specific effect on the $30 million in outstanding quotations.
- Backlog Conversion: Monitor the conversion rate of the $9.04 million backlog into actual revenue for fiscal 1998.
- Inventory Valuation: Assess the adequacy of remaining inventory reserves given the recent $385,000 write-off and the reduction in backlog.
- Patent Commercialization: Track the commercialization progress of the three newly patented technologies (dental implant, naval transformer, military antenna) to validate the growth strategy.
- Dividend Sustainability: Confirm that the $0.70 per share dividend remains sustainable given the reduced sales volume and the need to fund R&D and capital expenditures.